BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25983004)

  • 1. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition.
    Zhang L; Quan H; Wang S; Li X; Che X
    Tumour Biol; 2015 Sep; 36(10):8121-6. PubMed ID: 25983004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
    Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
    Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
    Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
    Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
    Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
    Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.
    Zheng J; Zhang Y; Cai S; Dong L; Hu X; Chen MB; Zhu YH
    Cancer Lett; 2020 Apr; 476():129-139. PubMed ID: 32081805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.
    Hou L; Chen J; Zheng Y; Wu C
    Tumour Biol; 2016 Apr; 37(4):5185-92. PubMed ID: 26548866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
    Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
    Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
    Su L; Han D; Wu J; Huo X
    Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
    Zhang X; Zhang X; Yu B; Hu R; Hao L
    Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
    Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
    Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
    Qin Q; Wei F; Zhang J; Li B
    Oncol Rep; 2017 Feb; 37(2):823-830. PubMed ID: 28075475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of FOXO1 in non-small cell lung cancer.
    Maekawa T; Maniwa Y; Doi T; Nishio W; Yoshimura M; Ohbayashi C; Hayashi Y; Okita Y
    Oncol Rep; 2009 Jul; 22(1):57-64. PubMed ID: 19513505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.